在心血管疾病治疗中,铜恒温和铜
Lifang Yang1, Pingping Yang1, Gregory Y H Lip2
1Department of Anesthesiology, Xi'an Children Hospital, Xi'an, Shaanxi, China.
Trends in pharmacological sciences
|July 27, 2023
概括
铜平衡对于预防心血管疾病 (CVD) 至关重要. 这项研究探讨了铜不平衡和细胞死亡类型的亡是如何导致心血管疾病的,这表明了新的治疗点.
科学领域:
- 生物化学 生物化学
- 心血管生物学 心血管生物学
- 细胞死亡研究 细胞死亡研究
背景情况:
- 铜 (Cu) 稳态对于人类健康至关重要,不平衡与病理状况有关,包括心血管疾病 (CVD).
- 像Cu补充剂,纳米载体和化剂这样的现有疗法是有前途的,但Cu在心血管疾病中的具体作用尚未得到充分理解.
- 新发现的一种调节性细胞死亡形式,即cuproptosis,在心血管病理学中提出了潜在的研究领域.
研究的目的:
- 讨论铜双体静止在各种心血管疾病中的影响.
- 探索cuproptosis在心血管疾病的发展和进展中的潜在作用.
- 评估连接铜不平衡和细胞死亡与心血管病理的潜在细胞机制.
主要方法:
- 文献综述和现有关于铜代谢和心血管疾病的研究的综合.
- 分析与铜恒温和调节细胞死亡相关的细胞机制.
- 对潜在的治疗策略的评估,以向CVD中的铜失调和cuproptosis.
主要成果:
- 铜双体静止 (超负荷和缺乏) 都与心血管疾病的发病有关.
- cuproptosis 是一种依赖铜的细胞死亡途径,正在成为心血管疾病病理学的重要因素.
- 了解这些机制为新的治疗干预提供了洞察力.
结论:
- 准铜体静止和铜体亡是一个有前途的新策略,用于管理心血管疾病.
- 需要进一步研究铜和铜死在心血管疾病中的确切作用.
- 这种方法可能会为患有心血管疾病的患者带来新的治疗途径.
相关概念视频
Cardiovascular Drugs: Classification based on Therapeutic Indications
2.9K
Cardiovascular diseases, encompassing a range of conditions, can significantly affect the heart's operations and the overall circulatory system. These conditions impair the heart's ability to pump blood, leading to a deficit in oxygen supply to crucial organs. Anomalies in the heart's electrical system, known as arrhythmias, can cause heartbeats to accelerate or slow down. Usually, heart rates increase during physical activity and decrease while resting or sleeping. However,...
2.9K
Regulation of the Cardiovascular System
1.2K
The regulation of the cardiovascular system allows the body to adapt to various demands and maintain homeostasis.
The regulation of the cardiovascular system involves the autonomic nervous system (ANS), baroreceptors, and chemoreceptors, ensuring that heart rate and blood pressure are appropriately modulated in response to varying physiological demands.
The ANS comprises two main divisions: the sympathetic and parasympathetic nervous systems. The sympathetic nervous system enhances...
The regulation of the cardiovascular system involves the autonomic nervous system (ANS), baroreceptors, and chemoreceptors, ensuring that heart rate and blood pressure are appropriately modulated in response to varying physiological demands.
The ANS comprises two main divisions: the sympathetic and parasympathetic nervous systems. The sympathetic nervous system enhances...
1.2K
Hypertension and Regulation of Blood Pressure
2.1K
Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
2.1K
Hypertension II: Pathophysiology
16
Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
16
Hormonal Regulation of Blood Pressure
2.7K
Endocrinal or hormonal intervention in the cardiovascular system is predominantly exerted by the catecholamines - epinephrine and norepinephrine, as well as a slew of hormones that interact with renal function to modulate blood volume.
Epinephrine and Norepinephrine
The adrenal medulla releases epinephrine and norepinephrine, catecholamines that enhance and extend the sympathetic or "fight or flight" physiological response. These hormones escalate heart rate and the force of contraction...
Epinephrine and Norepinephrine
The adrenal medulla releases epinephrine and norepinephrine, catecholamines that enhance and extend the sympathetic or "fight or flight" physiological response. These hormones escalate heart rate and the force of contraction...
2.7K
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
119
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
119


